LivaNova today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints.

Researchers used this home sleep study data to determine each person’s apnea-hypopnea index, the number of times per hour that breathing stops or is reduced. Researchers then compared how well ...

Opens in a new tab or window Vitamin D deficiency was significantly associated with increased obstructive sleep apnea (OSA) ...

The main measure of a sleep study – the apnea-hypopnea index, or AHI – doesn’t always correlate with symptoms, he said. And not all cases of sleep apnea need to be treated.How sleep apnea is ...

Already multitool smart devices, Apple Watches added another buzzworthy feature last month: an app to detect sleep apnea.

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

Researchers have identified that children deficient in vitamin D experience more severe symptoms of obstructive sleep apnea ...

BOSTON, Nov. 11, 2024 /PRNewswire/ -- Medical AI company HoneyNaps has published a paper demonstrating the clinical value and efficacy of its sleep disorder diagnostic algorithm, SOMNUM, in a leading ...

The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA in adults and moderate-to-severe OSA in children ages 6 to 17, such as ...